Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 4, 2004, Pages 425-428

  Zachou, Kalliopi ^a   Rigopoulou, Eirini ^a   Liaskos, Christos ^a   Patsiaoura, Kalliopi ^b   Makri, Eirini ^a   Stathakis, Nikolaos ^a   Dalekos, Georgios N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b Ippokration Hospital Thessaloniki   (Greece)

Author keywords

Antimitochondrial antibodies; Eosinophilia; Primary biliary cirrhosis; Ursodeoxycholic acid

Indexed keywords

ALKALINE PHOSPHATASE; MITOCHONDRION ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; LABORATORY TEST; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER FUNCTION TEST; LYMPHOCYTE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ALKALINE PHOSPHATASE; ANTIBODIES; CHOLAGOGUES AND CHOLERETICS; EOSINOPHILIA; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; MITOCHONDRIA, LIVER; URSODEOXYCHOLIC ACID;

EID: 1842452860     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200404000-00011     Document Type: Article

References (17)

1. Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350:875-879.
2. Neuberger J. Eosinophils and primary biliary cirrhosis - stoking the fire? Hepatology 1999; 30:335-337.
3. Terasaki S, Nakanuma Y, Yamazaki M, Unoura M. Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology 1993; 17:206-212.
4. Martinez OM, Villanueva JC, Gershwin GE, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21:113-119.
5. Miyaguchi S, Oda M, Tamano M, Matsubara K, Ishikawa Y, Kaneko H, et al. Elevation of serum eosinophil cationic protein in primary biliary cirrhosis. Int Hepatol Commun 1994; 2:285-288.
6. Yamazaki K, Nakadate I, Suzuki K, Sato S, Masuda T. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996; 91:516-522.
7. Miyaguchi S, Oda M, Mori M, Imaeda H, Tsuzuki Y, Saito H, et al. Immunohistochemical characterization of hepatic eosinophil cationic protein in primary biliary cirrhosis. Int Hepatol Commun 1996; 5:207-214.
8. Nakamura A, Yamazaki K, Suzuki K, Sato S. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 1997; 92:2245-2249.
9. Yamazaki K, Suzuki K, Nakamura A, Sato S, Lindor KD, Batts KP, et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 1999; 30:71-78.
10. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978; 379:103-112.
11. Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995; 181:723-733.
12. Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25:791-796.
13. Shindo M, Mullin GE, Braun-Elert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (HBV). Clin Exp Immunol 1996; 105:254-259.
14. Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallati H, Lohr HF, et al. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch A Pathol Anat Histol 1997; 431:119-124.
15. Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 1997; 17:115-123.
16. Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, Fukui H, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992; 16:358-364.
17. Miyaguchi S, Oda M, Saito H, Ishii H. Novel therapeutic approach to primary biliary cirrhosis patients: anti-eosinophil strategy. Hepatogastroenterology 1998; 45:1457-1461.